Heima vs Injective — how do they compare? Heima trades at Rp1,910 (market cap Rp183,56M, Rp241,24M 24h volume), while Injective trades at Rp93,269 (market cap Rp9,26T, Rp1,73T 24h volume). The key difference: Injective is far larger — about 50446.7× Heima's market cap, and Heima's supply is capped (97,8M / 100M HEI (98%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Heima for 12 Days and Injective for 36 Days on average.
| HEI | INJ | |
|---|---|---|
Market Cap | Rp183,56M | Rp9,26T |
Volume (24h) | Rp241,24M | Rp1,73T |
Circulating Supply | 97,8M / 100M HEI (98%) | 100M INJ |
Typical Hold Time | 12 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Heima (HEI) is trading at Rp1,874.82 with a market cap of Rp180.39 million, showing a bullish technical signal supported by moving averages. The token is near full circulation at 98%, with a short average hold time of 12 days. Current price sits between support at Rp1,753 and resistance at Rp2,195, indicating potential for upward movement if bullish momentum holds.
Overall outlook is cautiously optimistic due to technical strength, but limited fundamental updates and low liquidity pose risks. Key opportunities include breakout potential above resistance, while major risks involve high volatility and thin trading volumes. Investors should monitor for increased network activity or exchange listings to confirm sustainability.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
What Pluang investors did over the last 30 days
Latest headlines on both assets
As an evolution of the Litentry Network, the Heima Network was developed focusing on decentralized identity and privacy solutions. Building on this foundation, Heima expanded its scope to address cross-chain asset management and multi-chain interoperability.
Read more on HEI →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →